1. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells
- Author
-
Lucie Peduto, Marie Cherrier, Matthias Lochner, Francina Langa, Shinichiro Sawa, Mustapha Si-Tahar, James P. Di Santo, Gérard Eberl, Dieter Riethmacher, Rosa Varona, Hugot, Bérengère, Développement des Tissus Lymphoïdes, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Centre d'Ingénierie génétique murine - Mouse Genetics Engineering Center (CIGM), Institut Pasteur [Paris] (IP), Department of Immunology and Oncology, Universidad Autónoma de Madrid (UAM)-Centro Nacional de Biotecnología [Madrid] (CNB-CSIC), Consejo Superior de Investigaciones Científicas [Madrid] (CSIC)-Consejo Superior de Investigaciones Científicas [Madrid] (CSIC), Development and Regeneration, Human Genetics Division, University of Southampton, Défense innée et inflammation, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cytokines et Développement Lymphoïde, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris], Universidad Autonoma de Madrid (UAM)-Centro Nacional de Biotecnologia, Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], and Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
MESH: Nuclear Receptor Subfamily 1, Group F, Member 3 ,MESH: Inflammation ,MESH: Interleukin-10 ,Receptors, Retinoic Acid ,MESH: Interleukin-17 ,T-Lymphocytes ,MESH: Flow Cytometry ,T-Lymphocytes, Regulatory ,Mice ,0302 clinical medicine ,MESH: Receptors, Interleukin-12 ,RAR-related orphan receptor gamma ,Genes, Reporter ,Immunology and Allergy ,MESH: Animals ,MESH: Genetic Variation ,0303 health sciences ,education.field_of_study ,Receptors, Thyroid Hormone ,Interleukin-17 ,Receptors, Interleukin-12 ,FOXP3 ,hemic and immune systems ,Forkhead Transcription Factors ,Articles ,Nuclear Receptor Subfamily 1, Group F, Member 3 ,Flow Cytometry ,Interleukin-10 ,Interleukin 10 ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,Interleukin 17 ,medicine.medical_specialty ,[SDV.IMM] Life Sciences [q-bio]/Immunology ,MESH: Mice, Transgenic ,Immunology ,Population ,chemical and pharmacologic phenomena ,Mice, Transgenic ,Biology ,Article ,Proinflammatory cytokine ,03 medical and health sciences ,MESH: Forkhead Transcription Factors ,Internal medicine ,medicine ,Animals ,MESH: Receptors, Thyroid Hormone ,education ,MESH: Mice ,030304 developmental biology ,MESH: Receptors, Retinoic Acid ,Inflammation ,Interleukin-6 ,MESH: T-Lymphocytes, Regulatory ,T-cell receptor ,MESH: Genes, Reporter ,Genetic Variation ,Molecular biology ,MESH: Interleukin-6 ,CCL20 ,Endocrinology ,MESH: T-Lymphocytes ,030215 immunology - Abstract
The nuclear hormone receptor retinoic acid receptor-related orphan receptor gamma t (RORgamma t) is required for the generation of T helper 17 cells expressing the proinflammatory cytokine interleukin (IL)-17. In vivo, however, less than half of RORgamma t(+) T cells express IL-17. We report here that RORgamma t(+) T alphabeta cells include Foxp3(+) cells that coexist with IL-17-producing RORgamma t(+) T alphabeta cells in all tissues examined. The Foxp3(+) RORgamma t(+) T alphabeta express IL-10 and CCL20, and function as regulatory T cells. Furthermore, the ratio of Foxp3(+) to IL-17-producing RORgamma t(+) T alphabeta cells remains remarkably constant in mice enduring infection and inflammation. This equilibrium is tuned in favor of IL-10 production by Foxp3 and CCL20, and in favor of IL-17 production by IL-6 and IL-23. In the lung and skin, the largest population of RORgamma t(+) T cells express the gammadelta T cell receptor and produce the highest levels of IL-17 independently of IL-6. Thus, potentially antagonistic proinflammatory IL-17-producing and regulatory Foxp3(+) RORgamma t(+) T cells coexist and are tightly controlled, suggesting that a perturbed equilibrium in RORgamma t(+) T cells might lead to decreased immunoreactivity or, in contrast, to pathological inflammation.
- Published
- 2008